CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
Stanford University
Stanford University
Poseida Therapeutics, Inc.
LTZ Therapeutics, Inc.
Verismo Therapeutics
University Health Network, Toronto
University of Arizona
Mayo Clinic
Chengdu Zenitar Biomedical Technology Co., Ltd
University of Nebraska
Florida International University